8.44 USD
↗ 0.24 (2.93%)AT CLOSE (11:59 AM EDT)
Kyverna Therapeutics, Inc. Common Stock
KYTXNASDAQ • USD
8.29
↘ 0.16 (1.84%)
POST MARKET (AS OF 07:02 PM EDT)
Post Market
AS OF 07:02 PM EDT
8.29
↘ 0.16 (1.84%)
Market: CLOSED
Kyverna Therapeutics, Inc. Common Stock (KYTX) trades at $8.44 per share. KYTX shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics suggest KYTX is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Jun 26, 2026.
Open?$8.12
High?$8.54
Low?$8.05
Prev. Close?$8.20
Volume?6.8M
Avg. Volume?1.0M
VWAP?$8.31
Rel. Volume?6.48x
Bid / Ask
Bid?$6.83 × 100
Ask?$10.61 × 100
Spread?$3.78
Midpoint?$8.72
Valuation & Ratios
Market Cap?513.1M
Shares Out?60.8M
Float?35.7M
Float %?59.1%
P/E Ratio?N/A
P/B Ratio?2.62
EPS?-$2.57
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.
Themes
Employees
129
Market Cap
498.5M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2024-02-08
Address
5980 HORTON STREET
EMERYVILLE, CA 94608
Phone: (510) 626-8331
EMERYVILLE, CA 94608
Phone: (510) 626-8331
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?18
Momentum?77
Short Sent.?40
Piotroski F-Score?0/9Weak
Altman Z-Score?1.37Distress
Confidence?47%Low
Short InterestHigh
Short % of Float?17.00%High
Short Interest?6.1M
Days to Cover?8.4
Free Float35.7M
Avg Daily Volume720.9K
Settlement Date2026-06-15
Financial Health
Current Ratio?8.15Strong
Quick Ratio?8.15Strong
Cash Ratio?1.08Strong
Debt/Equity?0.13Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.62CHEAP▾
Peers100
S&P62
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-3.1CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-80.0%WEAK▾
S&P3
ROA?-60.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-150399000
Enterprise Value?$506.0M
Fundamentals ratios updated end of day